Search Results - Bernard Bénichou

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis.

    Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. by Bernard Bénichou, Jack L. Strominger

    Published 1991
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease

    Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease by Jean-Claude Lubanda, Ene Anijalg, Vladimı́r Bzdúch, Beth L. Thurberg, Bernard Bénichou, Anna Tylki‐Szymańska

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Large deletion of the peroxisomal acyl-CoA oxidase gene in pseudoneonatal adrenoleukodystrophy.

    Large deletion of the peroxisomal acyl-CoA oxidase gene in pseudoneonatal adrenoleukodystrophy. by B. Fournier, Jean Marie Saudubray, Bernard Bénichou, Stanislas Lyonnet, A Munnich, Hans Clevers, Bwee Tien Poll‐The

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Mapping of X-Linked Myxomatous Valvular Dystrophy to Chromosome Xq28

    Mapping of X-Linked Myxomatous Valvular Dystrophy to Chromosome Xq28 by Florence Kyndt, Jean‐Jacques Schott, Jean‐Noël Trochu, Florence Baranger, O. Herbert, Valerie E. Scott, Édith Fressinaud, Albert David, Jean‐Paul Moisan, Jean-Brieuc Bouhour, Hervé Le Marec, Bernard Bénichou

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Identification and characterization of a spinal muscular atrophy-determining gene

    Identification and characterization of a spinal muscular atrophy-determining gene by Suzie Lefebvre, Lydie Bürglen, Sophie Reboullet, Olivier Clermont, Philippe Burlet, Louis Viollet, Bernard Bénichou, Corinne Cruaud, Philippe Millasseau, Massimo Zeviani, Denis Le Paslier, J Frézal, Daniel Cohen, Jean Weissenbach, Arnold Münnich, Judith Melki

    Published 1995
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Characterization of Early Disease Status in Treatment-Naive Male Paediatric Patients with Fabry Disease Enrolled in a Randomized Clinical Trial

    Characterization of Early Disease Status in Treatment-Naive Male Paediatric Patients with Fabry Disease Enrolled in a Randomized Clinical Trial by Frits A. Wijburg, Bernard Bénichou, Daniel G. Bichet, Lorne A. Clarke, Gabriela Dostálová, Alejandro Fainboim, Andreas Fellgiebel, Cassiano Mateus Forcelini, Kristina An Haack, Robert J. Hopkin, Michael Mauer, Behzad Najafian, C. Ronald Scott, Suma P. Shankar, Beth L. Thurberg, Camilla Tøndel, Anna Tylki‐Szymańska, Uma Ramaswami

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial

    Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial by Uma Ramaswami, Daniel G. Bichet, Lorne A. Clarke, Gabriela Dostálová, Alejandro Fainboim, Andreas Fellgiebel, Cassiano Mateus Forcelini, Kristina An Haack, Robert J. Hopkin, Michael Mauer, Behzad Najafian, C. Ronald Scott, Suma P. Shankar, Beth L. Thurberg, Camilla Tøndel, Anna Tylki‐Szymańska, Bernard Bénichou, Frits A. Wijburg

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: